Trial Profile
Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2013
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 15 Aug 2013 New trial record